Advanced search
Publication Cover
Infection and Drug Resistance Volume 15, 2022 - Issue
Submit an article Journal homepage
106
Views
1
CrossRef citations to date
0
Altmetric
CASE SERIES

Two Cases Report of Intrathecal Tigecycline Therapy for Intracranial Infection with Acinetobacter baumannii and Review of Literatures

Guanlin HuangDepartment of Neurosurgery, Ganzhou People’s Hospital, Ganzhou, Jiangxi, 341000, People’s Republic of China
,
Wentao LaiDepartment of Neurosurgery, Ganzhou People’s Hospital, Ganzhou, Jiangxi, 341000, People’s Republic of China
,
Daxing WuDepartment of Neurosurgery, Ganzhou People’s Hospital, Ganzhou, Jiangxi, 341000, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-7601-8256
ORCID Icon,
Qianliang HuangDepartment of Neurosurgery, Ganzhou People’s Hospital, Ganzhou, Jiangxi, 341000, People’s Republic of China
,
Qi ZhongDepartment of Neurosurgery, Ganzhou People’s Hospital, Ganzhou, Jiangxi, 341000, People’s Republic of China
&
Xinyun YeDepartment of Neurosurgery, Ganzhou People’s Hospital, Ganzhou, Jiangxi, 341000, People’s Republic of ChinaCorrespondence[email protected]
Pages 2211-2217 | Published online: 26 Apr 2022

References

  • Zhan R, Zhu Y, Shen Y, et al. Post-operative central nervous system infections after cranial surgery in China: incidence, causative agents, and risk factors in 1470 patients. Eur J Clin Microbiol Infect Dis. 2014;33(5):861–866. doi:10.1007/s10096-013-2026-2
  • Ma YF, Wen L, Zhu Y. Prospective study evaluating post-operative central nervous system infections following cranial surgery. Br J Neurosurg. 2019;33(1):80–83. doi:10.1080/02688697.2018.1519112
  • Long W, Yuan J, Liu J, et al. Multidrug resistant brain abscess due to Acinetobacter baumannii ventriculitis cleared by intraventricular and intravenous tigecycline therapy: a case report and review of literature. Front Neurol. 2018;9:518. doi:10.3389/fneur.2018.00518
  • Bethesda (MD);Tigecycline. 2012. Clinical and Research Information on Drug and Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012. Tigecycline. [Updated 2019 Jan 23].
  • Tsimogianni A, Alexandropoulos P, Chantziara V, et al. Intrathecal or intraventricular administration of colistin, vancomycin and amikacin for central nervous system infections in neurosurgical patients in an intensive care unit. Int J Antimicrob Agents. 2017;49(3):389–390. doi:10.1016/j.ijantimicag.2017.01.002
  • Ng J, Gosbell IB, Kelly JA, Boyle MJ, Ferguson JK. Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review. J Antimicrob Chemother. 2006;58(5):1078–1081. doi:10.1093/jac/dkl347
  • Liang W, Yuan-Run Z, Min Y. Clinical presentations and outcomes of post-operative central nervous system infection caused by multi-drug-resistant/extensively drug-resistant Acinetobacter baumannii: a Retrospective Study. Surg Infect. 2019;20(6):460–464. doi:10.1089/sur.2018.286
  • Lauretti L, D’Alessandris QG, Fantoni M, et al. First reported case of intraventricular tigecycline for meningitis from extremely drug-resistant Acinetobacter baumannii. J Neurosurg. 2017;127(2):370–373. doi:10.3171/2016.6.JNS16352
  • Fang YQ, Zhan RC, Jia W, Zhang BQ, Wang JJ. A case report of intraventricular tigecycline therapy for intracranial infection with extremely drug resistant Acinetobacter baumannii. Medicine. 2017;96(31):e7703. doi:10.1097/MD.0000000000007703
  • Chusri S, Sakarunchai I, Kositpantawong N, et al. Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant acinetobacter baumannii. Int J Antimicrob Agents. 2018;51(4):646–650. doi:10.1016/j.ijantimicag.2017.12.002
  • Barberán J, Salso S, Alhambra A. [Tigecycline: 10 years of history and still in full force]. Rev Esp Quimioter. 2015;28(2):61–78. Spanish.
  • Tsolaki V, Karvouniaris M, Manoulakas E, et al. Intraventricular CNS treatment with Colistin-Tigecycline combination: a case series. J Crit Care. 2018;47:338–341. doi:10.1016/j.jcrc.2018.07.025
  • Karaiskos I, Galani L, Baziaka F, Giamarellou H. Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review. Int J Antimicrob Agents. 2013;41(6):499–508. doi:10.1016/j.ijantimicag.2013.02.006
  • Imberti R, Iotti GA, Regazzi M. Intraventricular or intrathecal colistin for the treatment of central nervous system infections caused by multidrug-resistant Gram-negative bacteria. Expert Rev Anti Infect Ther. 2014;12(4):471–478. doi:10.1586/14787210.2014.896740
  • Bargiacchi O, De Rosa FG. Intrathecal or intraventricular colistin: a review. Infez Med. 2016;24(1):3–11.
  • Pankey GA. Tigecycline. J Antimicrob Chemother. 2005;56(3):470–480. doi:10.1093/jac/dki248

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.